IC

Ikarian Capital Portfolio holdings

AUM $302M
1-Year Est. Return 65.21%
This Quarter Est. Return
1 Year Est. Return
+65.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$241M
AUM Growth
-$68K
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
106
New
Increased
Reduced
Closed

Top Buys

1
+$10.6M
2
+$9.86M
3
+$8.27M
4
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$7.32M
5
APLS icon
Apellis Pharmaceuticals
APLS
+$6.6M

Top Sells

1
+$17.5M
2
+$10.2M
3
+$5.94M
4
CLDX icon
Celldex Therapeutics
CLDX
+$5.81M
5
ETNB icon
89bio
ETNB
+$5.78M

Sector Composition

1 Healthcare 97.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$267K 0.06%
962
77
$252K 0.06%
24,843
+24,541
78
$219K 0.05%
219,501
79
$194K 0.04%
20,450
80
$182K 0.04%
4,519
81
$148K 0.03%
65,491
82
$148K 0.03%
448,101
83
$133K 0.03%
176,980
84
$132K 0.03%
+32,786
85
$95K 0.02%
136,059
86
$93.4K 0.02%
7,918
87
$60K 0.01%
+367,112
88
$18.2K ﹤0.01%
75
89
$11K ﹤0.01%
+76
90
$7.69K ﹤0.01%
6,100
91
– –
0
92
– –
0
93
– –
-30,286
94
– –
-11,568
95
– –
-454,000
96
– –
0
97
– –
0
98
– –
-10,000
99
– –
0
100
– –
0
1 2 3
4
5